InvestorsHub Logo
Followers 13
Posts 795
Boards Moderated 0
Alias Born 03/03/2010

Re: None

Wednesday, 04/08/2015 8:37:12 AM

Wednesday, April 08, 2015 8:37:12 AM

Post# of 401611
Does anyone have a guess what the SEC filing below might be about?

10-Qs are about company performance; disclosure of relevant financial information. What in a 10-Q would require confidential treatment?

Thanks.

Kind regards,
Minding

==============

From http://www.sec.gov/Archives/edgar/data/1053369/999999999715007521/filename1.pdf

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION March 17, 2015
ORDER GRANTING CONFIDENTIAL TREATMENT UNDER THE SECURITIES EXCHANGE ACT OF 1934
Elite Pharmaceuticals, Inc.
File No. 001-15697 - CF#32086 _____________________
Elite Pharmaceuticals, Inc. submitted an application under Rule 24b-2 requesting confidential treatment for information it excluded from the Exhibits to a Form 10-Q filed on February 17, 2015.
Based on representations by Elite Pharmaceuticals, Inc., that this information qualifies as confidential commercial or financial information under the Freedom of Information Act, 5 U.S.C. 552(b)(6), the Division of Corporation Finance has determined not to publicly disclose it. Accordingly, excluded information from the following exhibit(s) will not be released to the public for the time period(s) specified:
Exhibit 10.82 through June 23, 2016
For the Commission, by the Division of Corporation Finance, pursuant to delegated authority:
Brent J. Fields Deputy Secretary
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News